|
Resolution: standard / high Figure 1.
Analysis population. Footnote: *Subjects could be excluded for more than 1 reason. ITT, intent-to-treat;
mITT, modified intent-to-treat; TGC, tigecycline; Comp, comparator. c-mITT, clinical
modified intent-to-treat; TOC, test-of-cure; m-mITT, microbiologic-modified intent-to-treat;
CE, clinically evaluable; ME, microbiologically evaluable.
Matthews et al. BMC Infectious Diseases 2012 12:297 doi:10.1186/1471-2334-12-297 |